Evidence map›Paper›PMID 38548987›Full record

ArticleAnnals of nuclear medicine2024

Manual on the proper use of the

Tadashi Watabe, Masao Namba, Sachiko Yanagida, Yoshihide Nakamura, Takahiro Yamada, Saori Tatsuno, Aritoshi Ri, Shuhei Yoshida, Kumiko Uyama, Seigo Kinuya and 2 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of nuclear medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Tadashi WatabeDepartment of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan. watabe.tadashi.med@osaka-u.ac.jp.ORCID http://orcid.org/0000-0001-8658-2395
Masao NambaJapan Radioisotope Association, 2-28-45 Honkomagome, Bunkyo-ku, Tokyo, 113-0021, Japan.
Sachiko YanagidaJapan Radioisotope Association, 2-28-45 Honkomagome, Bunkyo-ku, Tokyo, 113-0021, Japan.
Yoshihide NakamuraChiyoda Technol Corporation, 1-7-12 Yushima, Bunkyo-ku, Tokyo, 113-8681, Japan.
Takahiro YamadaAtomic Energy Research Institute, Kindai University, 3-4-1 Kowakae, Higashi, Osaka, 577-8502, Japan.
Saori TatsunoFaculty of Medicine, Kindai University, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Aritoshi RiFaculty of Medicine, Kindai University, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Shuhei YoshidaFaculty of Medicine, Kindai University, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Kumiko UyamaFaculty of Medicine, Kindai University, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Seigo KinuyaJapanese Society of Nuclear Medicine, 3-1-17 Nishi-Azabu, Minato-ku, Tokyo, 106-0031, Japan.
Noriyuki TomiyamaDepartment of Radiology, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
Makoto HosonoFaculty of Medicine, Kindai University, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Kindai University · JPJapan Radioisotope Association · JPThe University of Osaka · JP

Funding

Ministry of Health, Labour and Welfare, Japan 22IA1010
6 · The paper itself

Abstract

Recently, an astatine-labeled prostate-specific membrane antigen (PSMA) ligand ([

Indexed as

Prostatic NeoplasmsRadiopharmaceuticalsHumansJapanLigandsMaleProstate-Specific AntigenLigandsProstate-Specific AntigenRadiopharmaceuticalsAstatineProstate cancerRadiation exposureSafety managementTargeted alpha therapy

Identifiers

PMID38548987
PMCPMC11016504
OpenAlexW4393253345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.